Dimensional Fund Advisors LP Harvard Bioscience Inc Transaction History

Dimensional Fund Advisors LP

$405 Billion
Q4 2024

A detailed history of Dimensional Fund Advisors LP transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 1,665,113 shares of HBIO stock, worth $1.96 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,665,113

Previous 1,715,879 2.96%

Holding current value

$1.96 Million

Previous $4.62 Million 23.88%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$2.02 - $2.82 $102,547 - $143,160	-50,766 Reduced 2.96%	1,665,113 $3.51 Million
Q3 2024 Nov 07, 2024	SELL	$2.64 - $3.54 $295,070 - $395,662	-111,769 Reduced 6.12%	1,715,879 $4.62 Million
Q2 2024 Aug 09, 2024	SELL	$2.77 - $4.63 $273,338 - $456,879	-98,678 Reduced 5.12%	1,827,648 $5.21 Million
Q1 2024 May 10, 2024	BUY	$4.02 - $5.39 $2,777 - $3,724	691 Added 0.04%	1,926,326 $8.17 Million
Q4 2023 Feb 07, 2024	SELL	$4.0 - $5.49 $33,324 - $45,737	-8,331 Reduced 0.43%	1,925,635 $10.3 Million
Q3 2023 Nov 09, 2023	BUY	$4.0 - $5.82 $465,348 - $677,081	116,337 Added 6.4%	1,933,966 $8.32 Million
Q2 2023 Aug 09, 2023	BUY	$4.19 - $6.16 $303,758 - $446,575	72,496 Added 4.15%	1,817,629 $9.98 Million
Q1 2023 May 12, 2023	BUY	$2.45 - $4.22 $9,763 - $16,816	3,985 Added 0.23%	1,745,133 $7.33 Million
Q4 2022 Feb 09, 2023	SELL	$2.12 - $2.86 $2,694 - $3,635	-1,271 Reduced 0.07%	1,741,148 $4.82 Million
Q3 2022 Nov 10, 2022	SELL	$2.33 - $3.92 $315,535 - $530,858	-135,423 Reduced 7.21%	1,742,419 $4.46 Million
Q2 2022 Aug 12, 2022	SELL	$3.28 - $6.42 $682 - $1,335	-208 Reduced 0.01%	1,877,842 $6.76 Million
Q1 2022 May 13, 2022	SELL	$5.16 - $7.14 $28,627 - $39,612	-5,548 Reduced 0.29%	1,878,050 $11.7 Million
Q4 2021 Feb 09, 2022	SELL	$6.37 - $8.18 $523,747 - $672,567	-82,221 Reduced 4.18%	1,883,598 $13.3 Million
Q3 2021 Nov 12, 2021	BUY	$6.98 - $8.47 $71,817 - $87,147	10,289 Added 0.53%	1,965,819 $13.7 Million
Q2 2021 Aug 12, 2021	SELL	$5.44 - $8.4 $105,465 - $162,850	-19,387 Reduced 0.98%	1,955,530 $16.3 Million
Q1 2021 May 14, 2021	SELL	$3.91 - $6.99 $203,609 - $363,997	-52,074 Reduced 2.57%	1,974,917 $10.8 Million
Q4 2020 Feb 25, 2021	BUY	$3.0 - $4.5 $6.08 Million - $9.12 Million	2,026,991 New	2,026,991 $8.7 Million

Others Institutions Holding HBIO

# of Institutions

Shares Held

31.3M

Call Options Held

Put Options Held

15K

View Full List

About HARVARD BIOSCIENCE INC

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $49.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

More about HBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Harvard Bioscience Inc Transaction History